Healthcare & Pharmaceuticals

Pharma and biotech M&A activity to hit fresh highs in 2018

Hyesung Lim The year 2018 is set to be an M&A heavy one for the pharmaceutical industry, as companies look to boost drug portfolios, offset revenue declines from patent expiries, and compete with innovative rivals. The U.S. tax overhaul and repatriation of overseas cash is expected to inject billions into big pharma, boosting the incentive…

Read More

Flotation of Siemens’ healthcare unit to be the largest German IPO in two decades

Hyesung Lim On Wednesday, the European engineering conglomerate Siemens AG announced its plans to list its diagnostics technology division Healthineers on the Frankfurt stock exchange during the first half of 2018. The partial flotation of this €40bn medical solutions business is anticipated to be the largest public offering in Germany since the €13bn listing of…

Read More

The implications of technology in healthcare

Hyesung Lim With advancements in technology causing far-reaching disruptions across the business landscape, there has been a race among companies in all regions and industry sectors to reap the competitive advantages offered by the latest innovations. Pharmaceutical and healthcare companies have not been an exception to such a pervasive trend. Recent movements show that they…

Read More

Pharma companies are safe from Amazon – but for how long?

Jake Buckley For the past few weeks it has appeared increasingly likely that e-commerce giant Amazon has been preparing for a move into the drug selling business. In the last couple of days, however, Amazon has told regulators it will not ‘ship or sell drugs’ and instead seem set to tackle the simpler market of…

Read More

Integra Acquires J&J Neurosurgery Unit

Pavit Bangur Fresh from its $30 billion acquisition of Actelion, Europe’s biggest biotech company, Johnson & Johnson (J&J), the largest publically traded healthcare company, are on the opposing end. Integra LifeSciences Holdings Corp is looking to acquire J&J’s Codman Neurosurgery unit for $1.045 billion; its intention is to expand its presence outside of the United…

Read More

The Heroes of CRISPR?

Patricija Petkeviciute The US Patent Office has handed the win in CRISPR battle to the Broad Institute of Cambridge that is affiliated with Harvard and MIT. The case was originally brought by the University of California, Berkeley, that challenged the patents held by the Broad Institute. It was Jennifer Doudna, a biochemist of UC Berkeley,…

Read More

Creative Deal-making in Big Pharma: J&J-Actelion

Patricija Petkeviciute Following months of complex negotiations, the US pharma giant Johnson & Johnson is acquiring Actelion for $30bn in an all-cash deal. Actelion is a Swiss blood pressure specialist and a leader in the field of pulmonary arterial hypertension. The acquisition marks the first big pharmaceuticals transaction of the year. Actelion is being sold…

Read More

Tackling Drug Resistance

Pavit Bangur Elon Musk’s SpaceX is planning on sending up a sample of MRSA to the International Space Station (ISS) on its next flight on the 14th of February. MRSA is a prevalent type of staph bacteria. Around 1 in 3 people carry harmless staph bacteria and 1 in 30 are colonized by the MRSA…

Read More